Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

N/A
6(85.7%)
Phase 3
1(14.3%)
7Total
N/A(6)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT06338397Not ApplicableRecruiting

Social & Affective Cognition in Alzheimer's Disease & Associated Disorders

Role: collaborator

NCT04661280Phase 3Recruiting

Donepezil Versus Non-drug Treatment in Alzheimer's Disease.

Role: collaborator

NCT04701957Not ApplicableRecruiting

The Ketogenic Diet for Alzheimer's Disease

Role: collaborator

NCT05516667Recruiting

Cohort of Patients with Alzheimer's Disease and Their Families.

Role: collaborator

NCT04150198Not ApplicableRecruiting

MECHANISMS OF NEURONAL RESILIENCE IN ALZHEIMER'S DISEASE AND ITS FOCAL VARIANTS: A PET/MR STUDY

Role: collaborator

NCT02626377Not ApplicableTerminated

Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-Comté

Role: collaborator

NCT04146688Not ApplicableUnknown

Nonverbal Communication in Aged People

Role: collaborator

NCT02299154Not ApplicableUnknown

Memory Problems Perceptions Among Patients and Accompaniers During Diagnosis Process :

Role: collaborator

All 8 trials loaded